BCMU
ABBV icon

BlueCrest Capital Management (UK)’s AbbVie ABBV Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,050
Closed -$1.16M – 562
2014
Q1 		$1.13M Buy
+22,050
New +$1.11M 0.06% 271

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlueCrest Capital Management (UK)'s ABBV Position: Q2 2014 in Review

BlueCrest Capital Management (UK) sold out of AbbVie (ABBV) in Q2 2014, closing a stake of 22,050 shares — an estimated $1.16M sold.

BlueCrest Capital Management (UK) first reported a position in ABBV in Q1 2014 and held it in 1 quarter. The position peaked at $1.13M in Q1 2014. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

  • BlueCrest Capital Management (UK) reported no remaining AbbVie position as of Q2 2014 after selling out during the quarter.
  • BlueCrest Capital Management (UK) sold 22,050 AbbVie shares in Q2 2014, an estimated $1.16M.
  • BlueCrest Capital Management (UK) first reported a position in AbbVie in Q1 2014 and held it in 1 quarter.
  • BlueCrest Capital Management (UK)'s AbbVie position peaked at $1.13M in Q1 2014.
  • 1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q2 2014, filed 15 Aug 2014.